# Stage 04 — Multimodal Integration Architecture Report
**Personalized Precision Medicine for Oncology Treatment Optimization**
**Author**: Integration Engineer

> [!IMPORTANT]
> **MANDATORY SYNTHETIC DATA & REGULATORY DISCLAIMER**:
> *Synthetic research integration only. This system is not clinically validated and must not be interpreted as evidence of clinical efficacy, diagnostic performance, or treatment recommendation.*
> All upstream stages (01 ML, 02 DL, 03 NLP) and the integration layer operate strictly on synthetic oncology research records. This software is a decision-support research prototype and is NOT an approved medical device.


## 1. Architectural Philosophy
The Stage 04 Integration subsystem establishes an end-to-end, decoupled, strictly read-only decision-support framework connecting:
1. **Stage 01 (ML)**: Tabular machine learning baseline severity scoring.
2. **Stage 02 (DL)**: Multimodal deep learning imaging (histopathology) and temporal sequence kinetics.
3. **Stage 03 (NLP)**: Acute clinical encounter urgency categorization and structured medical entity recognition.

## 2. Decoupled Modular Design
- **Adapters Layer**: Standardizes heterogeneous upstream output formats without modifying upstream checkpoints or data splits.
- **Alignment Layer**: Conducts exact patient matching, reports unmatched cohorts, and maintains an audited benchmark crosswalk.
- **Normalization Layer**: Validates probability simplex constraints ($0 \le p \le 1$, $\sum p_i pprox 1.0$) and scales confidence scores.
- **Fusion Engine**: Dynamic available-modality renormalized fusion avoiding zero-risk penalization.
- **Safety Engine**: 4-rule clinical guardrails for acute escalation, sentinel terms, discordance, and missing modalities.
- **Inference & Explainability**: Public API and decomposed risk attribution narratives.
